ACTON, Mass.–(BUSINESS WIRE)–Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced plans to release its financial results for the first quarter of 2023 on May 4, 2023 after the close of the financial markets. In connection with the release, management … [Read more…]
Achieved third consecutive quarter of revenue growth with new high of $19.3 million in the fourth quarter 2022, representing a 26.0% increase over same period in 2021 Exceeded annual revenue guidance generating $72.8 million in 2022, representing a 17.6% increase year-over-year and the highest full-year revenue to date for the Company Reduced debt to $10.0 … [Read more…]
CAMBRIDGE, Mass.–(BUSINESS WIRE)–FogPharma®, a biopharmaceutical company committed to transforming the lives of patients through a new precision medicine approach widely applicable to important and challenging intracellular targets, today announced that Mathai Mammen, M.D., Ph.D., will join the company as chairman, president and chief executive officer. Dr. Mammen brings significant global R&D and corporate leadership experience … [Read more…]
PROMISE II Trial Met Primary Endpoint Therapy Demonstrates 76% Limb Salvage in Patients with Chronic Limb-Threatening Ischemia Who Otherwise Faced Amputation PARIS–(BUSINESS WIRE)–#amputation—LimFlow SA, a pioneer in the development of minimally-invasive technology for the treatment of chronic limb-threatening ischemia (CLTI), a severe form of peripheral artery disease (PAD), announced today that results from the PROMISE … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Pharmacovigilance Europe Congress 2023” conference has been added to ResearchAndMarkets.com’s offering. After witnessing outstanding success in the previous Pharmacovigilance conferences, Pharmacovigilance Europe 2022 will gather the top notch Industry experts from Pharma/Biotech and Clinical Research Organisations. Why Attend This Conference? Listen to the top Pharma/Biotech Industry pioneers who will deliver the latest cutting … [Read more…]
Collaboration to make use of Confo’s unique suite of ConfoBody®-enabled technologies for fragment- and structure-based drug design Confo to receive upfront and milestone payments totaling EUR 168M Tiered royalties payable to Confo on net sales from resulting products GHENT, Belgium–(BUSINESS WIRE)–Confo Therapeutics, a leader in the discovery of medicines targeting G-protein coupled receptors (GPCRs), today … [Read more…]
VANCOUVER, British Columbia–(BUSINESS WIRE)–Gandeeva Therapeutics, Inc., a precision medicine company focused on designing and developing novel therapeutics guided by cryogenic electron microscopy (cryo-EM) and machine learning, announced today the initiation of a research collaboration with Moderna Inc. (NASDAQ: MRNA) to explore applications of Gandeeva’s differentiated technology platform for a Moderna program. “We are excited to … [Read more…]
International availability of first-of-its-kind digitally connected Hydrafacial device follows strong U.S. introduction and adoption LONG BEACH, Calif.–(BUSINESS WIRE)–The Beauty Health Company (NASDAQ: SKIN), home to flagship brand Hydrafacial, today announced the international launch of Hydrafacial™ Syndeo™, the award-winning next generation connected delivery system. The expansion brings Syndeo to Europe and Asia, following the device’s successful … [Read more…]
MONTPELLIER, France–(BUSINESS WIRE)–Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in gene therapies in the inner ear, announces that its Annual Financial Report for the year ending December 31, 2022, is available to the public and filed with the French financial market authority (AMF). The 2022 Annual Financial Report includes: … [Read more…]
Galderma will present results from the innovative Sculptra® Cheek Wrinkle study, which demonstrate the long-lasting results over a 24-month period of the treatment for cheek wrinkle correction with significant improvements in skin firmness and radiance1 Data from the Alluzience® STAR study will also be featured, demonstrating sustained aesthetic improvement in glabellar lines up to month … [Read more…]
